Based on a comparison of 9 firms among Czech Pharmaceutical Companies, Sanofi-Aventis Czech Republic had the biggest debt relative to its equity at the end of 2017 followed by Bayer Czech Republic and Pfizer Czech Republic.
Sanofi-Aventis Czech Republic net debt reached CZK 774 mil. and accounted for 103% of equity at the end of 2017. The ratio is down 55.7% when compared to the previous year. Historically, the firm’s net debt to equity reached an all time high of 336% in 2004 and an all time low of 57.8% in 2015.
When compared to EBITDA, net debt amounted to 15.3x at the end of the year. The ratio reached an all time high of 29.5x in 2004 and an all time low of 4.16x in 2005.
Comparing Sanofi-Aventis Czech Republic with its closest peers, Bayer Czech Republic posted net debt to equity of 94.4% and 2.49x when compared to EBITDA at the end of 2017. Pfizer Czech Republic ended the year 2016 with a net debt at 24.2% of equity and 2.10x when compared to its EBITDA while Roche Czech Republic had net debt at 14.2% of equity and 0.428x to EBITDA at the end of the year.
You can see all the companies net debt/equity data on the Net Debt/Equity indicator page or you can download a special statistical dossier on the Czech Pharmaceutical Companies in the reports section.
Helgi Library 
